跳至主要内容
临床试验/CTRI/2021/06/033912
CTRI/2021/06/033912尚未招募2 期

Study of Impact of adding Low Dose Pulmonary Radiotherapy to Moderate COVID-19 pneumonia patients. - IMpaCt-RT

All India Institute of Medical Sciences Patna0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1)Age >= 18 years
  • 2)Patients with confirmed diagnosis of SARS-Cov2 infection by RT-PCR on nasopharyngeal swab and / or bronchoalveolar lavage (BAL)
  • 3)Patients having MOHFW Moderate disease with SpO2 < 94% on Room Air and Respiratory rate > 20 Breaths per minute on Room Air with fewer than 8 days of symptom onset and currently receiving standard medication for COVID-19 at appropriate doses. Covid-19 classification criteria led down by MOHFW, Govt. Of India (Appendix 1)
  • 4)Suggestive picture finding for interstitial pneumonia on chest X-ray and / or chest CT (optional)
  • 5)Ability to understand and sign informed consent.
  • 6)Ability to acquire and maintain the set-up necessary for the delivery of radiotherapy treatment

排除标准

  • 1)Patients with MOHFW defined severe disease.
  • 2)Patients undergoing invasive mechanical ventilation.
  • 3)Patients with active autoimmune systemic diseases.
  • 4)Hemodynamically unstable patients.
  • 5)Patients with a positive pregnancy test.
  • 6)Impossibility to maintain the set-up necessary for radiotherapy treatment.

研究者

发起方
All India Institute of Medical Sciences Patna

相似试验